Print Page Current Date/Time: Sunday 20th August 2017 - 13:06:01
Great Basin Scientific, Inc (OTC: GBSN)
Great Basin Scientific is a molecular diagnostics company dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. With a compelling customer-centric business model, no-cost instrumentation, simple workflow, low-cost assays and support included at no-charge, Great Basin removes the barriers typically found in adopting molecular diagnostics.
Great Basin Scientific is innovating molecular diagnostics.
We are dedicated to delivering the industry’s most simple, yet powerful sample-to-result molecular diagnostics platform that provides fast, multiple-pathogen diagnoses of infectious diseases.
Our technology empowers health providers with answers to quickly and accurately define a clear treatment path for improved patient outcomes, shorter hospital stays, and dollars saved in hospitalization costs per patient.
Our vision is to make molecular diagnostic testing so easy and cost-effective that every patient will be tested for every serious infection, thereby reducing misdiagnoses and significantly limiting the spread of infectious disease.
- Seethru Equity Updates GBSN Report Following Latest FDA Clearance
July 18, 2017
- Stool Bacterial Pathogens Panel Receives FDA Clearance; Commercial Rollout Begins Immediately
July 13, 2017
- Investor Presentation
July 7, 2017
- Seethru Equity Issues Update Report on GBSN
July 5, 2017
- Great Basin Provides Business Update
June 26, 2017
Recent Events and Presentations
420 E South Temple, Suite 520
Salt Lake City, UT 84111
Investor Relations Contact
This site includes forward-looking statement regarding events, trends and business prospects which may affect future operating results and financial position, including but not limited to statements regarding the Company’s business strategy and vision. Forward-looking statements involve risk and uncertainties, which could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risk and uncertainties include, but are not limited to: (i) the Company’s limited operating history and history or losses; (ii) the Company’s ability to develop and commercialize new products and the timing of commercialization; (iii) the Company’s ability to obtain capital when needed; and (iv) other risks set forth in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the most recent 10-K and 10-Q. These forward-looking statements speak only as of the date hereof and Great Basin Scientific specifically disclaims any obligation to update these forward-looking statements, except as required by law.